Article
Meet Us at ASH – Happy hour event
ASH is just over a month away. Come meet with the GTC team and its co-op partners at our happy hour event. Download your invitation
November 4, 2022 9:34 am
gtc
Read More »
Innovation
Genomic Testing Cooperative Implementing AI, Molecular Profiling to Improve Cancer Diagnosis
CHICAGO – With the publication of a paper validating two artificial intelligence-based algorithms for assisting pathologists in molecular profiling of patients, the Genomic Testing Cooperative
November 3, 2022 9:02 am
Press Releases
GTC research is being presented at ASCO 2020
GTC research is being presented at ASCO 2020 in the following three abstracts. 1. FGFR expression, fusion and mutation as detected by NGS sequencing of
May 20, 2020 9:50 am
Genomics
GTC was honored to be featured in the Orange County Business Journal
GTC featured in the Orange County Business Journal on September 30, 2019 [Click image to enlarge]
October 16, 2019 10:24 am
Innovation
Time Matters on Health Tests [TAT-NGS]
We’re always competing with ourselves on improving turn around time (TAT) because we know patients depend on the results Most studies suggest that treatment delay
July 17, 2019 11:31 am
Press Releases
Myelodysplastic Syndrome (MDS)
MDS is defined as ineffective hematopoiesis characterized by adequate or increased hematologic elements in bone marrow with peripheral cytopenia. Therefore, the presence of cytopenia in
June 26, 2019 3:00 am
Press Releases
Comprehensive PIK3CA Mutation Analysis
When you order GTC Breast Cancer Profile The FDA has approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine
June 4, 2019 10:00 am
Press Releases
The FDA has Approved Drugs for FGFR Abnormalities
The FDA has approved Balversa (erdafitinib) as a treatment for adult patients with locally advanced or metastatic bladder cancer that have FGFR3 or FGFR2 abnormalities
May 27, 2019 11:00 am
Press Releases
GTC Presents at the 2019 ASCO Annual Meeting
Genomic Testing Cooperative (GTC) and Collaborators to Present data Resulting from its Proprietary DNA and RNA Profiling of Diffuse Large B-cell Lymphoma at the 2019
May 22, 2019 4:00 am
Press Releases
Study shows that RNA Plus DNA profiling significantly enhanced Drug Matching
Recent study published in Nature Medicine (Rodon et al, Nature Medicine volume 25, pages 751–758, 2019) showed that molecular profiling using both DNA and RNA
May 16, 2019 9:18 am